Archive for the ‘08-2007 (August 2007)’ Category

Good Palliative Care for a Patient with Schizophrenia Dying of Emphysema

Sunday, August 5th, 2007

by Linda J. Griffith, MD

Dr. Griffith is Board Certified, American Board of Psychiatry and Neurology, American Board of Family Medicine, American Board of Hospice and Palliative Medicine, Certificate of Added Qualifications in Geriatrics; is Medical Director, Consolidated Care, Inc., Champaign, Logan, Union Counties, Ohio; and is Clinical Assistant Professor, Boonshoft School of Medicine,Wright State University, Dayton, Ohio; Dr. Gillig is Professor of Psychiatry, Department of Psychiatry, School of Medicine, Wright State University, Dayton, Ohio.

(more…)

Blood Brain Barrier: The Role of Pyridoxine

Sunday, August 5th, 2007

by Atmaram Yarlagadda, MD; and Anita H. Clayton, MD

Dr. Yarlagadda is from McDonald Army Health Center, Fort Eustis, Virginia, and from Clinical Associates of Tidewater, Newport News, Virginia; and Dr. Clayton is Professor, Department of Psychiatry & Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia

(more…)

A Multidimensional Approach to Medication Selection in the Treatment of Children and Adolescents with ADHD

Sunday, August 5th, 2007

by Atilla Turgay, MD, FRCPC

Dr. Atilla Turgay is from the University of Toronto and the Scarborough Hospital.

(more…)

Alzheimer’s Therapies

Sunday, August 5th, 2007

by Elisa F. Cascade; Amir H. Kalali, MD; and Edmund Howe, MD, JD

Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Howe is Professor, Department of Psychiatry, Uniformed Services University of the Health Sciences, Bethesda, Maryland.

(more…)

The FDA and the Drug Approval Process

Sunday, August 5th, 2007

by William D. Schwieterman, MD, PhD; and Steven D. Targum, MD

Dr. Targum is on the editorial board of Psychiatry 2007. Presently, he is Chief Medical Officer at Brain Cells Inc., an executive-in-residence at Oxford BioScience Partners, and a consultant in psychiatry at the Massachusetts General Hospital, Boston, Massachusetts; and Dr. Schwieterman is an independent consultant to Tekgenics, Inc., Mobile, Alabama.

(more…)

Lisdexamfetamine Dimesylate: The First Prodrug Stimulant

Friday, August 3rd, 2007

by David W. Goodman, MD

Dr. Goodman is from the Adult Attention Deficit Disorder Center of Maryland, Johns Hopkins at Green Spring Station, Lutherville, Maryland; and Assistant Professor, Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Baltimore, Maryland.

(more…)

An Atomoxetine Tutorial

Friday, August 3rd, 2007

by David Feifel, MD, PhD

Dr. Feifel is Associate Professor In Residence, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San Diego Medical Center, San Diego, California.

(more…)

  • Recent Comments